Cargando…
Correction To: Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663427/ https://www.ncbi.nlm.nih.gov/pubmed/36376272 http://dx.doi.org/10.1038/s41413-022-00238-5 |
| _version_ | 1784830873814695936 |
|---|---|
| author | Kan, Chen Yang, Jiazhao Fan, Haitao Dai, Yuanjuan Wang, Xingxing Chen, Rui Liu, Jia Meng, Xiangyue Wang, Wei Li, Guiling Zhou, Jiao Zhang, Ya Zhu, Wanbo Fang, Shiyuan Wei, Haiming Zheng, Hong Wang, Siying Ni, Fang |
| author_facet | Kan, Chen Yang, Jiazhao Fan, Haitao Dai, Yuanjuan Wang, Xingxing Chen, Rui Liu, Jia Meng, Xiangyue Wang, Wei Li, Guiling Zhou, Jiao Zhang, Ya Zhu, Wanbo Fang, Shiyuan Wei, Haiming Zheng, Hong Wang, Siying Ni, Fang |
| author_sort | Kan, Chen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9663427 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96634272022-11-15 Correction To: Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss Kan, Chen Yang, Jiazhao Fan, Haitao Dai, Yuanjuan Wang, Xingxing Chen, Rui Liu, Jia Meng, Xiangyue Wang, Wei Li, Guiling Zhou, Jiao Zhang, Ya Zhu, Wanbo Fang, Shiyuan Wei, Haiming Zheng, Hong Wang, Siying Ni, Fang Bone Res Correction Nature Publishing Group UK 2022-11-15 /pmc/articles/PMC9663427/ /pubmed/36376272 http://dx.doi.org/10.1038/s41413-022-00238-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Kan, Chen Yang, Jiazhao Fan, Haitao Dai, Yuanjuan Wang, Xingxing Chen, Rui Liu, Jia Meng, Xiangyue Wang, Wei Li, Guiling Zhou, Jiao Zhang, Ya Zhu, Wanbo Fang, Shiyuan Wei, Haiming Zheng, Hong Wang, Siying Ni, Fang Correction To: Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss |
| title | Correction To: Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss |
| title_full | Correction To: Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss |
| title_fullStr | Correction To: Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss |
| title_full_unstemmed | Correction To: Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss |
| title_short | Correction To: Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss |
| title_sort | correction to: fetuin-a is an immunomodulator and a potential therapeutic option in bmp4-dependent heterotopic ossification and associated bone mass loss |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663427/ https://www.ncbi.nlm.nih.gov/pubmed/36376272 http://dx.doi.org/10.1038/s41413-022-00238-5 |
| work_keys_str_mv | AT kanchen correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT yangjiazhao correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT fanhaitao correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT daiyuanjuan correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT wangxingxing correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT chenrui correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT liujia correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT mengxiangyue correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT wangwei correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT liguiling correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT zhoujiao correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT zhangya correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT zhuwanbo correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT fangshiyuan correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT weihaiming correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT zhenghong correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT wangsiying correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss AT nifang correctiontofetuinaisanimmunomodulatorandapotentialtherapeuticoptioninbmp4dependentheterotopicossificationandassociatedbonemassloss |